Alexion Pharmaceuticals. ALXN has been notified of an
unsolicited "mini-tender" offer by TRC Capital Corporation to purchase
up to 1.5 million shares, or approximately 0.77%, of the outstanding
Alexion common stock at a price of $90.50 per share. TRC's offer price
represents approximately a 5.06% discount to the closing price of
Alexion common stock on February 5, 2013, the last closing price on the
day prior to the date of the offer. In addition, TRC's offer is subject
to numerous conditions.
Alexion does not endorse TRC's offer and recommends that shareholders
reject the offer and do not tender their shares. This offer is a
so-called "mini-tender" offer at a price below the current market price
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in